Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "Jadenu 90 mg" (38)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Deferasirox (V03AC03) 38 products
WHO-DDD
DrugBank.ca
L
IP
Deferasirox Spirig HC 900 mg
30
790.68
876.35
10 %
Coated tablets: Deferasiroxum 900 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Deferasirox Spirig HC 900 mg
90
2016.23
2209.20
10 %
Coated tablets: Deferasiroxum 900 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Jadenu 90 mg
30
191.20
221.40
10 %
Coated tablets: Deferasiroxum 90 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Jadenu 90 mg
90
487.57
539.15
10 %
Coated tablets: Deferasiroxum 90 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Jadenu 180 mg
30
313.58
352.65
10 %
Coated tablets: Deferasiroxum 180 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Jadenu 180 mg
90
799.62
873.75
10 %
Coated tablets: Deferasiroxum 180 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Jadenu 360 mg
30
514.27
567.80
10 %
Coated tablets: Deferasiroxum 360 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Jadenu 360 mg
90
1311.37
1422.45
10 %
Coated tablets: Deferasiroxum 360 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Deferasirox Accord 90 mg
30
143.39
172.35
10 %
Coated tablets: Deferasiroxum 90 mg
Accord Healthcare AG
B / SL / SG
FB
G
L
IP
CI
Deferasirox Accord 90 mg
90
365.68
414.10
10 %
Coated tablets: Deferasiroxum 90 mg
Accord Healthcare AG
B / SL / SG
FB
G
L
IP
Deferasirox Accord 180 mg
30
235.18
272.20
10 %
Coated tablets: Deferasiroxum 180 mg
Accord Healthcare AG
B / SL / SG
FB
G
L
IP
Deferasirox Accord 180 mg
90
599.72
668.65
10 %
Coated tablets: Deferasiroxum 180 mg
Accord Healthcare AG
B / SL / SG
FB
G
L
IP
Deferasirox Accord 360 mg
30
385.70
435.90
10 %
Coated tablets: Deferasiroxum 360 mg
Accord Healthcare AG
B / SL / SG
FB
G
L
IP
Deferasirox Accord 360 mg
90
983.53
1086.05
10 %
Coated tablets: Deferasiroxum 360 mg
Accord Healthcare AG
B / SL / SG
FB
G
L
IP
CI
Deferasirox Spirig HC 90 mg
30
143.41
172.40
10 %
Coated tablets: Deferasiroxum 90 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Deferasirox Spirig HC 90 mg
90
365.68
414.10
10 %
Coated tablets: Deferasiroxum 90 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Deferasirox Spirig HC 180 mg
30
235.19
272.20
10 %
Coated tablets: Deferasiroxum 180 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Deferasirox Spirig HC 180 mg
90
599.72
668.65
10 %
Coated tablets: Deferasiroxum 180 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Deferasirox Spirig HC 360 mg
30
385.70
435.90
10 %
Coated tablets: Deferasiroxum 360 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
Deferasirox Spirig HC 360 mg
90
983.53
1086.05
10 %
Coated tablets: Deferasiroxum 360 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Deferasirox-Mepha 90 mg
30
143.41
172.40
10 %
Coated tablets: Deferasiroxum 90 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Deferasirox-Mepha 90 mg
90
365.68
414.10
10 %
Coated tablets: Deferasiroxum 90 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Deferasirox-Mepha 180 mg
30
235.19
272.20
10 %
Coated tablets: Deferasiroxum 180 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Deferasirox-Mepha 180 mg
90
599.72
668.65
10 %
Coated tablets: Deferasiroxum 180 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Deferasirox-Mepha 360 mg
30
385.70
435.90
10 %
Coated tablets: Deferasiroxum 360 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
Deferasirox-Mepha 360 mg
90
983.53
1086.05
10 %
Coated tablets: Deferasiroxum 360 mg
Mepha Pharma AG
B / SL / SG
FB
G
SIP
IP
CI
Exjade 125 mg
28 Tablet(s)
390.38
464.55
k.A.
Dispersible Tablets: Deferasiroxum 125 mg
Novartis Pharma
Schweiz AG
B
FB
G
SIP
IP
CI
Exjade 125 mg
84 Tablet(s)
995.47
1153.30
k.A.
Dispersible Tablets: Deferasiroxum 125 mg
Novartis Pharma
Schweiz AG
B
FB
G
SIP
IP
CI
Exjade 250 mg
28 Tablet(s)
640.22
751.35
k.A.
Dispersible Tablets: Deferasiroxum 250 mg
Novartis Pharma
Schweiz AG
B
FB
G
SIP
IP
CI
Exjade 250 mg
84 Tablet(s)
1632.58
1852.05
k.A.
Dispersible Tablets: Deferasiroxum 250 mg
Novartis Pharma
Schweiz AG
B
FB
G
SIP
IP
CI
Exjade 500 mg
28 Tablet(s)
1049.97
1213.05
k.A.
Dispersible Tablets: Deferasiroxum 500 mg
Novartis Pharma
Schweiz AG
B
FB
G
SIP
IP
CI
Exjade 500 mg
84 Tablet(s)
2677.42
2990.35
k.A.
Dispersible Tablets: Deferasiroxum 500 mg
Novartis Pharma
Schweiz AG
B
FB
G
IP
CI
Deferasirox NOBEL 90 mg
30
218.47
267.20
k.A.
Coated tablets: Deferasiroxum 90 mg
NOBEL Pharma Schweiz AG
B
FB
G
IP
CI
Deferasirox NOBEL 90 mg
90
557.12
655.95
k.A.
Coated tablets: Deferasiroxum 90 mg
NOBEL Pharma Schweiz AG
B
FB
G
IP
Deferasirox NOBEL 180 mg
30
358.30
427.75
k.A.
Coated tablets: Deferasiroxum 180 mg
NOBEL Pharma Schweiz AG
B
FB
G
IP
Deferasirox NOBEL 180 mg
90
913.67
1063.55
k.A.
Coated tablets: Deferasiroxum 180 mg
NOBEL Pharma Schweiz AG
B
FB
G
IP
Deferasirox NOBEL 360 mg
30
587.62
691.00
k.A.
Coated tablets: Deferasiroxum 360 mg
NOBEL Pharma Schweiz AG
B
FB
G
IP
Deferasirox NOBEL 360 mg
90
1498.42
1704.90
k.A.
Coated tablets: Deferasiroxum 360 mg
NOBEL Pharma Schweiz AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home